FOLH1 and Familial prostate cancer: Positron emission tomography (PET) imaging is a common staging tool in a variety of malignancies, with early investigations demonstrating the potential utility of prostate-specific membrane antigen (PSMA) for the detection of prostate cancer [1, 2].